0 false false false false false false false false false true false false false false false false No description of principal activity 2022-07-01 Sage Accounts Production Advanced 2021 - FRS102_2021 xbrli:pure xbrli:shares iso4217:GBP 10240968 2022-07-01 2023-06-30 10240968 2023-06-30 10240968 2022-06-30 10240968 bus:Director1 2022-07-01 2023-06-30 10240968 core:WithinOneYear 2023-06-30 10240968 core:WithinOneYear 2022-06-30 10240968 core:ShareCapital 2023-06-30 10240968 core:ShareCapital 2022-06-30 10240968 core:RetainedEarningsAccumulatedLosses 2023-06-30 10240968 core:RetainedEarningsAccumulatedLosses 2022-06-30 10240968 bus:SmallEntities 2022-07-01 2023-06-30 10240968 bus:AuditExemptWithAccountantsReport 2022-07-01 2023-06-30 10240968 bus:FullAccounts 2022-07-01 2023-06-30 10240968 bus:SmallCompaniesRegimeForAccounts 2022-07-01 2023-06-30 10240968 bus:PrivateLimitedCompanyLtd 2022-07-01 2023-06-30
COMPANY REGISTRATION NUMBER: 10240968
Tribeca Health Limited
Filleted Unaudited Financial Statements
For the year ended
30 June 2023
Tribeca Health Limited
Statement of Financial Position
30 June 2023
2023
2022
Note
£
£
£
£
Current assets
Stocks
8,063
14,263
Debtors
5
18,602
25,440
Cash at bank and in hand
304
4,977
--------
--------
26,969
44,680
Creditors: amounts falling due within one year
6
7,843
15,064
--------
--------
Net current assets
19,126
29,616
--------
--------
Total assets less current liabilities
19,126
29,616
--------
--------
Net assets
19,126
29,616
--------
--------
Capital and reserves
Called up share capital
120
120
Profit and loss account
19,006
29,496
--------
--------
Shareholders funds
19,126
29,616
--------
--------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 30 June 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 30 March 2024 , and are signed on behalf of the board by:
Mr S Trinder
Director
Company registration number: 10240968
Tribeca Health Limited
Notes to the Financial Statements
Year ended 30 June 2023
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Ground Floor, 3 Wellbrook Court, Girton, Cambridge, CB3 0NA.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis. The financial statements are prepared in sterling, which is the functional currency of the entity.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for goods supplied, stated net of discounts and of Value Added Tax.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Foreign currencies
Foreign currency transactions are initially recorded in the functional currency, by applying the spot exchange rate as at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated at the exchange rate ruling at the reporting date, with any gains or losses being taken to the profit and loss account.
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.
4. Employee numbers
The average number of persons employed by the company during the year amounted to nil (2022: nil).
5. Debtors
2023
2022
£
£
Amounts owed by group undertakings and undertakings in which the company has a participating interest
18,321
25,005
Other debtors
281
435
--------
--------
18,602
25,440
--------
--------
6. Creditors: amounts falling due within one year
2023
2022
£
£
Trade creditors
1,416
4,621
Amounts owed to group undertakings and undertakings in which the company has a participating interest
108
108
Social security and other taxes
370
6,678
Other creditors
5,949
3,657
-------
--------
7,843
15,064
-------
--------